Silo Pharma Advances Canadian Patent for PTSD Therapy
SARASOTA, Fla., August 18, 2026 Silo Pharma, Inc. announced that the Canadian Intellectual Property Office (CIPO) has issued a...
SPC-15
Advertisement
Silo Pharma Gains European Patent for SPC-15 PTSD Therapy
SARASOTA, Fla., August 10, 2026 Silo Pharma, Inc. announced that the European Patent Office (EPO) has granted a patent...
Silo Pharma Advances SPC-15 PTSD Program Toward FDA Meeting
SARASOTA, Fla., June 29, 2026 Silo Pharma announced that it has initiated a drug-device robustness study for SPC-15, its...
Silo Pharma Moves SPC-15 Into Phase 1 Clinical Development
Sarasota, Florida | December 30, 2025 — Silo Pharma, Inc. has taken a key step toward early-stage clinical development...
Advertisement
